Immunological outcomes of new tuberculosis vaccine trials: WHO panel recommendations

Immunological outcomes of new tuberculosis vaccine trials: WHO panel recommendations

Show other versions (1)

Bibliografske podrobnosti
Main Authors:	Hanekom, W, Dockrell, H, Ottenhoff, T, Doherty, T, Fletcher, H, McShane, H, Weichold, F, Hoft, D, Parida, S, Fruth, U
Format:	Journal article
Jezik:	English
Izdano:	Public Library of Science 2008
Teme:	Medical sciences Vaccinology Infectious diseases

Podobne knjige/članki

Immunological outcomes of new tuberculosis vaccine trials: WHO panel recommendations.
od: Hanekom, W, et al.
Izdano: (2008)

Immunological outcomes of new tuberculosis vaccine trials: WHO panel recommendations.
od: Willem A Hanekom, et al.
Izdano: (2008-07-01)

Evaluation of a human BCG challenge model to assess antimycobacterial immunity induced by BCG and a candidate TB vaccine, MVA85A, alone and in combination
od: Harris, S, et al.
Izdano: (2013)

Immunogenicity and induction of immunological memory of the heptavalent pneumococcal conjugate vaccine in preterm UK infants
od: Ruggeberg, J, et al.
Izdano: (2007)

Inflammatory and myeloid-associated gene expression before and one day after infant vaccination with MVA85A correlates with induction of a T cell response.
od: Matsumiya, M, et al.
Izdano: (2014)

Evaluation of the immunological mechanisms induced by mycobacteria and the potential effect this may have on immunity induced by tuberculosis vaccines
od: Poyntz, HC
Izdano: (2012)

Editorial: Reverse Vaccinology
od: Richard Moxon, et al.
Izdano: (2019-12-01)

A simplified 4-site economical intradermal post-exposure rabies vaccine regimen: a randomised controlled comparison with standard methods
od: Warrell, M, et al.
Izdano: (2008)

Disease susceptibility to ST11 complex meningococci bearing serogroup C or W135 polysaccharide capsules, North America
od: Pollard, A, et al.
Izdano: (2004)

Development of antimalarial human monoclonal antibodies against Plasmodium falciparum
od: Wang, LT
Izdano: (2022)

Understanding vaccine induced protective immunity to Mycobacterium tuberculosis
od: Ronan, E
Izdano: (2011)

Understanding the link between interleukin 17 and vaccine-induced protection in tuberculosis
od: Griffiths, K
Izdano: (2012)

Innate immune responses to tuberculosis vaccines
od: Matsumiya, M
Izdano: (2014)

B cell responses to conjugate and polysaccharide meningococcal vaccines
od: Ramasamy, M
Izdano: (2012)

Malaria pre-erythrocytic stage vaccines: targeting antigen combinations
od: Bauza, K
Izdano: (2012)

New approaches for improving the immunogenicity of modified vaccinia virus Ankara as a recombinant vaccine vector
od: Alharbi, N
Izdano: (2014)

Host genetic factors and vaccine-induced immunity to hepatitis B virus infection
od: Hennig, B, et al.
Izdano: (2008)

Characterising immune responses to viral vectored vaccines against influenza and hepatitis C
od: Antrobus, R
Izdano: (2014)

Data Behind Vaccine Hesitancy and Latest Updates on Vaccines in the Pipeline—2019 Annual Conference on Vaccinology Research, April 3–5, 2019
od: William Schaffner, et al.
Izdano: (2020-01-01)

Control of typhoid fever: evaluating herd protection through public health use of typhoid VI polysaccharide vaccine
od: Ochiai, R
Izdano: (2011)

Antibody-based HIV-1 vaccines: recent developments and future directions
od: Montefiori, D, et al.
Izdano: (2007)

Analysis of b cell responses to blood-stage malaria antigens in humans following immunization with candidate vaccines and controlled human malaria infection
od: Elias, SC
Izdano: (2014)

The Vaccinia Virus A36R Protein Is a Type Ib Membrane Protein Present on Intracellular but Not Extracellular Enveloped Virus Particles
od: Van Eijl, H, et al.
Izdano: (2000)

Novel adenoviral vectored vaccines and the implications of viral diversity in therapeutic strategies against Hepatitis C Virus infection
od: Kelly, C
Izdano: (2013)

Epitope dominance studies with serotype O foot-and-mouth disease
od: Borley, DW
Izdano: (2012)

Long term efficacy of a pre-erythrocytic malaria vaccine and correlates of protection in children residing in a malaria endemic country
od: Olotu, A
Izdano: (2013)

Characterisation of T cells induced by candidate conserved region HIV-1 vaccines in healthy HIV-1/2 negative volunteers
od: Ahmed, T, et al.
Izdano: (2014)

HIV-specific interleukin-10 responses and immune modulation
od: Clutton, G
Izdano: (2012)

Vaccines for the 21st century
od: Isabel Delany, et al.
Izdano: (2014-05-01)

The role of lung tissue-resident memory T cells in protection against tuberculosis
od: Bull, N
Izdano: (2017)

The design and development of an HIV-1 vaccine to elicit a broadly neutralising antibody response
od: Wan, L, et al.
Izdano: (2012)

Evaluation of a potential vaccine against hyperinvasive serogroup B Neisseria meningitidis by assessment of the effects of surface-expressed Opacity-associated proteins on the immune system
od: Sadarangani, M
Izdano: (2011)

Architecture of the HIV-1 glycan shield
od: Pritchard, L
Izdano: (2014)

T-cell receptor (TCR) usage in HIV-2 infection
od: Moysi, E
Izdano: (2012)

Enhancing the efficacy of viral vector blood-stage malaria vaccines
od: Forbes, E
Izdano: (2011)

Haemophilus influenzae Type b vaccine failure in children is associated with inadequate production of high-quality antibody
od: Lee, Y, et al.
Izdano: (2008)

Editorial: Precision vaccinology for infectious diseases
od: Mahbuba Rahman, et al.
Izdano: (2024-04-01)

Vaccine Evolution and Its Application to Fight Modern Threats
od: Emanuele Andreano, et al.
Izdano: (2019-07-01)

Evaluation of the immunogenicity of a promising vaccine regimen to identify immune correlates of protection
od: Pinpathomrat, N
Izdano: (2018)

Global epidemiology of meningococcal disease and vaccine efficacy
od: Pollard, A
Izdano: (2004)